Maki Kanashiki

516 citations
9 papers · 396 indexed · h-index 6

Maki Kanashiki

9 papers receiving 385 citations

Peers

Maki Kanashiki
Comparison fields: 5 of 59
  • Nephrology 154
  • Cardiology and Cardiovascular Medicine 131
  • Pulmonary and Respiratory Medicine 113
  • Endocrinology, Diabetes and Metabolism 48
  • Oncology 56
Replace Ana Huelmos with:
Ana Huelmos Spain
Angelica Parodi Italy
Amret Hawfield United States
Sławomir Lizakowski Poland
H.‐H. Neumayer Germany
Fatih Öksüz Türkiye
Yosuke Tatami Japan
F Gómez-Campderá Spain
Onur Kaypaklı Türkiye
John G. Vlachojannis Greece
Maki Kanashiki relative to Ana Huelmos Spain Ana Huelmos's profile →
Citations per field
00.5×1.5×2.5×
Ana Huelmos · 1×
Citations per year

Countries citing papers authored by Maki Kanashiki

Since Specialization
Citations

This map shows the geographic impact of Maki Kanashiki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Kanashiki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Kanashiki more than expected).

Fields of papers citing papers by Maki Kanashiki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maki Kanashiki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Kanashiki. The network helps show where Maki Kanashiki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maki Kanashiki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maki Kanashiki Line = papers co-authored together Maki Kanashiki links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 201241
2
Abstract 9316: Intermittent Pattern of Atrial Fibrillation: An Extremely High Risk for Subsequent Stroke in the General Population.
20101
3 2006247
4 200540
5 200528
6 20047
7 20031
8
Time from finding abnormality on mass-screening to final diagnosis of lung cancer.
200329
9
[Alpha 1-antitrypsin deficiency (Siiyama) with pulmonary emphysema].
19992

About Maki Kanashiki

Maki Kanashiki is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Nephrology, having authored 9 papers that have together received 396 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (3 papers), Head and Neck Cancer Studies (2 papers), Esophageal Cancer Research and Treatment (2 papers), Blood Pressure and Hypertension Studies (2 papers), Sodium Intake and Health (1 paper), Machine Learning in Bioinformatics (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Nephrology (154 citations), Cardiology and Cardiovascular Medicine (131 citations) and Pulmonary and Respiratory Medicine (113 citations). Maki Kanashiki has collaborated with scholars based in Japan and United States. Frequent co-authors include Yoko Saito, Toshimi Sairenchi, Fujiko Irie, Kazumasa Yamagishi, Tadao Nose, Hiroyasu Iso, Hitoshi Ota, Satoyo Ikehara, Hiroaki Satoh and Hiroichi Ishikawa.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026